BRITTNEY LABOMBARD: Open Payments
NPI 1386376747 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,262 in 67 payments from 17 companies in 2025. Trend: 2023 $414 · 2024 $954 · 2025 $1,262
Food & beverage: $1,262
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $262 |
| AstraZeneca Pharmaceuticals LP | 6 | $186 |
| Lilly USA, LLC | 11 | $169 |
| PFIZER INC. | 10 | $154 |
| Novo Nordisk Inc | 6 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Astellas Pharma US Inc | 2 | $49 |
| Dexcom, Inc. | 1 | $38 |
| Exact Sciences Corporation | 2 | $37 |
Products named: VRAYLAR, QULIPTA, MOUNJARO, ELIQUIS, FARXIGA, AIRSUPRA, JARDIANCE, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
